404 - File or directory not found.

The page you are looking for might have been removed or had its name changed, or is temporarily unavailable.

Adverse events and device failures should be reported

Please report suspected adverse drug reactions (ADRs) and device failures to the MHRA through the Yellow Card scheme. You can report via:

• the Yellow Card website www.mhra.gov.uk/yellowcard
• the free Yellow Card app available from the Apple App Store or Google Play Store
• some clinical IT systems (EMIS/SystmOne/Vision/MiDatabank) for healthcare professionals

Alternatively, you can report suspected adverse drug reactions and device failures to the Yellow Card scheme by calling 0800 731 6789 for free, Monday to Friday between 9am and 5pm. You can leave a message outside of these hours.

When reporting please provide as much information as possible. By reporting adverse drug reactions and device failures, you can help provide more information on the safety of this medicine.

You can also report directly to the manufacturer at pv.uk@viatris.com

This website is owned and managed by Viatris. For more information visit viatris.co.uk


This is a promotional site intended for UK healthcare professionals. If you're a patient who has been prescribed Dymista® (azelastine hydrochloride/fluticasone propionate), please ​click here.

Dymista® is indicated for the relief of symptoms of moderate to severe seasonal and perennial allergic rhinitis if monotherapy with either intranasal antihistamine or glucocorticoid is not considered sufficient.​

Copyright © 2023 Viatris Inc All rights reserved. Dymista® is a registered trademark of Viatris Inc.

Viatris UK Healthcare Limited (company registration number 09189103), an English company with a registered office address at 20 Station Close, Potters Bar, Hertfordshire, EN6 1TL (VAT - 421 623 781)

Mylan Logo